The NIH Somatic Cell Genome Editing program

Area of Science:

• Biotechnology
• Genomics
• Medical Research

Background:

• Genome editing holds promise for improving human health.
• Current methods require further development for clinical application, especially for hard-to-reach tissues.

Purpose of the Study:

• To accelerate the development of safer and more effective somatic cell genome editing (SCGE) methods.
• To establish rigorous benchmarking and validation approaches for genome editing technologies.
• To create a comprehensive toolkit for the biomedical research community.

Main Methods:

• Developing and validating genome editing tools for somatic cells.
• Measuring genome modifications and their functional consequences in human cells.
• Conducting third-party validation in animal models (small and large).
• Developing in vivo cell tracking methods.

Main Results:

• The consortium plans to assemble validated datasets, genome editors, delivery technologies, and animal models into an SCGE Toolkit.
• The toolkit will include methods for inducing and measuring genome modifications and assessing downstream effects.
• Validation will involve rigorous testing in preclinical models.

Conclusions:

• The SCGE Toolkit will be widely disseminated to accelerate clinical development.
• This initiative aims to advance therapeutic applications of genome editing for diverse conditions.
• Standardized validation and accessible tools are crucial for translating genome editing into clinical practice.